Correlation Between Dermata Therapeutics and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and GT Biopharma, you can compare the effects of market volatilities on Dermata Therapeutics and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and GT Biopharma.
Diversification Opportunities for Dermata Therapeutics and GT Biopharma
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dermata and GTBP is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and GT Biopharma go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and GT Biopharma
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.0 times more return on investment than GT Biopharma. However, Dermata Therapeutics is 1.0 times less risky than GT Biopharma. It trades about 0.06 of its potential returns per unit of risk. GT Biopharma is currently generating about -0.07 per unit of risk. If you would invest 122.00 in Dermata Therapeutics on September 4, 2024 and sell it today you would earn a total of 5.00 from holding Dermata Therapeutics or generate 4.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. GT Biopharma
Performance |
| Timeline |
| Dermata Therapeutics |
| GT Biopharma |
Dermata Therapeutics and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and GT Biopharma
The main advantage of trading using opposite Dermata Therapeutics and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| Dermata Therapeutics vs. Candel Therapeutics | Dermata Therapeutics vs. Cingulate Warrants | Dermata Therapeutics vs. Unicycive Therapeutics | Dermata Therapeutics vs. Cardio Diagnostics Holdings |
| GT Biopharma vs. Candel Therapeutics | GT Biopharma vs. Cingulate Warrants | GT Biopharma vs. Unicycive Therapeutics | GT Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |